White River Junction, VT, United States of America

Joseph Robert Warfield

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Trishula Therapeutics, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Robert Warfield. Retrieved from https://idiyas.com/inventor/joseph-robert-warfield

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Robert Warfield: Innovator in Antibody Therapeutics

Introduction

Joseph Robert Warfield is a notable inventor based in White River Junction, Vermont. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions that address critical medical needs.

Latest Patents

Warfield holds a patent for Anti-CD39 antibodies. This patent provides antibodies that selectively bind to CD39 and its isoforms and homologs. Additionally, it includes compositions comprising these antibodies and outlines methods for their use, including therapeutic and diagnostic applications.

Career Highlights

Warfield is currently associated with Trishula Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in antibody technology positions him as a key player in the biotechnology sector.

Collaborations

He collaborates with talented individuals such as Vanessa Soros and Maria Kovalenko, contributing to a dynamic research environment that fosters innovation.

Conclusion

Joseph Robert Warfield's work in antibody therapeutics exemplifies the impact of innovative thinking in biotechnology. His contributions are paving the way for new therapeutic options in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…